{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:41:18Z","timestamp":1782135678859,"version":"3.54.5"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Radiol."],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) remains a major public health challenge in Vietnam and, according to GLOBOCAN 2022, accounted for 24,502 new cases in 2022, making it the second most common cancer and the leading cause of cancer-related mortality. Transarterial chemoembolization (TACE), introduced in 1977, is a pivotal treatment for unresectable HCC, delivering chemotherapeutic agents and embolic materials to induce tumor necrosis through cytotoxicity and ischemia. TACE is versatile and, in selected early-stage HCC (BCLC 0-A) treated with a highly selective approach, may achieve complete response; in intermediate-stage disease (BCLC B), it can prolong survival and enable downstaging, and in advanced-stage disease (BCLC C), it may complement systemic therapy. Despite its global use, TACE practices vary, and Vietnam lacks standardized guidelines tailored to its unique clinical landscape. The Vietnamese Society of Radiology and Nuclear Medicine and The Vietnamese Society of Interventional Radiology conducted three workshops in Da Nang, An Giang, and Can Tho between August and December 2024. These workshops engaged interventional radiologists from major hospitals and regional centers to develop consensus-based TACE recommendations. Through literature reviews, discussions, and physician voting, the recommendations cover pre-TACE diagnostic imaging, patient selection criteria, TACE techniques, choice of embolic materials and chemotherapeutic agents, intra- and post-procedure monitoring, and integration with combination therapies. This initiative aligns international standards with local needs, aiming to enhance the efficacy and consistency of TACE for HCC management in Vietnam.<\/jats:p>","DOI":"10.3389\/fradi.2026.1763042","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:53:56Z","timestamp":1776776036000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Vietnamese expert consensus on the treatment of hepatocellular carcinoma with transarterial chemoembolization"],"prefix":"10.3389","volume":"6","author":[{"given":"Vu Dang","family":"Luu","sequence":"first","affiliation":[{"name":"Department of Diagnostic Imaging, Hanoi Medical University","place":["Hanoi, Vietnam"]},{"name":"Institute for Radiology, Bach Mai Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Dang","family":"Tan","sequence":"additional","affiliation":[{"name":"Institute for Radiology, Bach Mai Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham Minh","family":"Thong","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Hanoi Medical University","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Van","family":"Khang","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Hanoi Medical University","place":["Hanoi, Vietnam"]},{"name":"Institute for Radiology, Bach Mai Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Thanh","family":"Dung","sequence":"additional","affiliation":[{"name":"Center for Diagnostic Imaging, Viet Duc University Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Trong","family":"Binh","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Hue University of Medicine and Pharmacy","place":["Hue, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Ngoc","family":"Trang","sequence":"additional","affiliation":[{"name":"Institute for Radiology, Bach Mai Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Ngoc","family":"Cuong","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Hanoi Medical University Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Dinh","family":"Luan","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Nhan Dan Gia Dinh Hospital","place":["Ho Chi Minh City, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngo Le","family":"Lam","sequence":"additional","affiliation":[{"name":"Center for Diagnostic Imaging, National Cancer Hospital (K Hospital)","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinh Ha","family":"Chau","sequence":"additional","affiliation":[{"name":"Institute for Radiology, Bach Mai Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Than Van","family":"Sy","sequence":"additional","affiliation":[{"name":"Center for Diagnostic Imaging, Viet Duc University Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Duy","family":"Anh","sequence":"additional","affiliation":[{"name":"Center for Diagnostic Imaging, National Cancer Hospital (K Hospital)","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Duc","family":"Tho","sequence":"additional","affiliation":[{"name":"Institute for Radiology, Bach Mai Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Duc","family":"Huy","sequence":"additional","affiliation":[{"name":"Institute for Radiology, Bach Mai Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang Ngoc","family":"Hieu","sequence":"additional","affiliation":[{"name":"Institute for Radiology, Bach Mai Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham Quang","family":"Son","sequence":"additional","affiliation":[{"name":"Institute for Radiology, Bach Mai Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Doan","family":"Tri","sequence":"additional","affiliation":[{"name":"Institute for Radiology, Bach Mai Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Dinh","family":"Huong","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Hanoi Oncology Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham Cam","family":"Phuong","sequence":"additional","affiliation":[{"name":"Center for Nuclear Medicine and Oncology, Bach Mai Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Tien","family":"Thinh","sequence":"additional","affiliation":[{"name":"Central Military Hospital 108","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vo Duy","family":"Thong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Medical Center, University of Medicine and Pharmacy at Ho Chi Minh City","place":["Ho Chi Minh City, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Tan","family":"Phat","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Cho Ray Hospital","place":["Ho Chi Minh City, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phan Thi Hong","family":"Duc","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Breast, and Urology, Ho Chi Minh City Oncology Hospital","place":["Ho Chi Minh City, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham Gia","family":"Anh","sequence":"additional","affiliation":[{"name":"Department of Oncology and Radiotherapy, Viet Duc University Hospital","place":["Hanoi, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vo Hoi Trung","family":"Truc","sequence":"additional","affiliation":[{"name":"Department of Liver Tumors, Cho Ray Hospital","place":["Ho Chi Minh City, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lam Quoc","family":"Trung","sequence":"additional","affiliation":[{"name":"Department of Chemotherapy, University Medical Center, University of Medicine and Pharmacy at Ho Chi Minh City","place":["Ho Chi Minh City, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Ba","family":"Thao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Nhan Dan Gia Dinh Hospital","place":["Ho Chi Minh City, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Tuan","family":"Anh","sequence":"additional","affiliation":[{"name":"Center for Oncology, Cho Ray Hospital","place":["Ho Chi Minh City, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Cong Duy","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, University Medical Center, University of Medicine and Pharmacy at Ho Chi Minh City","place":["Ho Chi Minh City, Vietnam"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1148\/radiology.148.2.6306721","article-title":"Hepatic artery embolization in 120 patients with unresectable hepatoma","volume":"148","author":"Yamada","year":"1983","journal-title":"Radiology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000514174","article-title":"Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update","volume":"10","author":"Kudo","year":"2021","journal-title":"Liver Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jhep.2014.01.006","article-title":"Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma","volume":"60","author":"Manini","year":"2014","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1148\/radiology.218.3.r01mr39763","article-title":"Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT","volume":"218","author":"Murakami","year":"2001","journal-title":"Radiology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1148\/radiology.183.3.1316622","article-title":"Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings","volume":"183","author":"Kadoya","year":"1992","journal-title":"Radiology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1148\/radiol.11101840","article-title":"Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging","volume":"261","author":"Sano","year":"2011","journal-title":"Radiology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2214\/AJR.09.3730","article-title":"Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI","volume":"195","author":"Goshima","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.ultrasmedbio.2009.05.013","article-title":"Definition of contrast enhancement phases of the liver using a perfluoro-based microbubble agent, perflubutane microbubbles","volume":"35","author":"Shunichi","year":"2009","journal-title":"Ultrasound Med Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2214\/AJR.08.1618","article-title":"Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial","volume":"193","author":"Moriyasu","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/ajg.2010.432","article-title":"Double-contrast ultrasound: a novel surveillance tool for hepatocellular carcinoma","volume":"106","author":"Kudo","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000122600","article-title":"Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, sonazoid","volume":"51","author":"Hatanaka","year":"2008","journal-title":"Intervirology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcu.22080","article-title":"The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced US","volume":"42","author":"Hatanaka","year":"2014","journal-title":"J Clin Ultrasound JCU"},{"key":"B14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3348\/kjr.2023.0385","article-title":"Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean liver cancer association","volume":"24","author":"Cho","year":"2023","journal-title":"Korean J Radiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00270-015-1208-y","article-title":"Treatment of liver tumors with lipiodol TACE: technical recommendations from experts opinion","volume":"39","author":"de Baere","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B16","first-page":"159","article-title":"Application of multislice spiral CT angiography on transcatheter arterial chemoembolization for hepatocellular carcinoma","volume":"28","author":"Huang","year":"2009","journal-title":"Ai Zheng"},{"key":"B17","first-page":"231","article-title":"[Diagnostic capability of multidetector CT for arterioportal shunt in hepatocellular carcinoma]","volume":"26","author":"Luo","year":"2004","journal-title":"Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.3748\/wjg.v11.i17.2666","article-title":"Capability of multidetector CT to diagnose hepatocellular carcinoma-associated arterioportal shunt","volume":"11","author":"Luo","year":"2005","journal-title":"World J Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL\u2013EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet (London, England)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1148\/radiol.2241011262","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials","volume":"224","author":"Camm\u00e0","year":"2002","journal-title":"Radiology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.annonc.2021.02.014","article-title":"Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO clinical practice guidelines","volume":"32","author":"Vogel","year":"2021","journal-title":"Ann Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/cancers13215475","article-title":"Changing the treatment paradigm for hepatocellular carcinoma using atezolizumab plus bevacizumab combination therapy","volume":"13","author":"Kudo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1159\/000480256","article-title":"Hepatic function during repeated TACE procedures and prognosis after introducing sorafenib in patients with unresectable hepatocellular carcinoma: multicenter analysis","volume":"35","author":"Hiraoka","year":"2017","journal-title":". Dig Dis (Basel, Switzerland)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/cancers11070952","article-title":"Impact of baseline ALBI grade on the outcomes of hepatocellular carcinoma patients treated with lenvatinib: a multicenter study","volume":"11","author":"Ueshima","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1200\/JCO.22.00392","article-title":"Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase III, randomized clinical trial (LAUNCH)","volume":"41","author":"Peng","year":"2023","journal-title":"J Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/14737140.2025.2489651","article-title":"The effectiveness and safety of therapies for hepatocellular carcinoma with tumor thrombus in the hepatic vein, inferior vena cava and\/or right atrium: a systematic review and single-arm meta-analysis","volume":"25","author":"Wang","year":"2025","journal-title":"Expert Rev Anticancer Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1159\/000549355","article-title":"Rechallenge with immune checkpoint inhibitors in patients with hepatocellular carcinoma: a narrative review","author":"Li","year":"2025","journal-title":"Liver Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3109\/00016925309136722","article-title":"Catheter replacement of the needle in percutaneous arteriography; a new technique","volume":"39","author":"Seldinger","year":"1953","journal-title":"Acta Radiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.jcin.2018.04.045","article-title":"Anatomic basis and physiological rationale of distal radial artery access for percutaneous coronary and endovascular procedures","volume":"11","author":"Sgueglia","year":"2018","journal-title":"J Am Coll Cardiol Intv"},{"key":"B36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12876-023-02646-1","article-title":"Transradial versus transfemoral approach for TACE: a retrospective study","volume":"23","author":"You","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jacc.2004.04.034","article-title":"Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; systematic overview and meta-analysis of randomized trials","volume":"44","author":"Agostoni","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.diii.2013.12.001","article-title":"Anatomy of liver arteries for interventional radiology","volume":"96","author":"Favelier","year":"2015","journal-title":"Diagn Interv Imaging"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3348\/kjr.2001.2.1.8","article-title":"Celiac axis stenosis: incidence and etiologies in asymptomatic individuals","volume":"2","author":"Park","year":"2001","journal-title":"Korean J Radiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s1051-0443(07)61845-4","article-title":"Transcatheter arterial chemoembolization for hepatocellular carcinomas in patients with celiac axis occlusion","volume":"13","author":"Kwon","year":"2002","journal-title":"J Vasc Intervent Radiol JVIR"},{"key":"B41","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1148\/rg.25si055508","article-title":"Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization","volume":"25","author":"Kim","year":"2005","journal-title":"Radiographics"},{"key":"B42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1148\/radiol.14131925","article-title":"How I do it: cone-beam CT during transarterial chemoembolization for liver cancer","volume":"274","author":"Tacher","year":"2015","journal-title":"Radiology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.jvir.2011.07.008","article-title":"Imaging guidance with C- arm CT: prospective evaluation of its impact on patient radiation exposure during transhepatic arterial chemoembolization","volume":"22","author":"Kothary","year":"2011","journal-title":"J Vasc Intervent Radiol JVIR"},{"key":"B44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s43055-022-00720-4","article-title":"The efficacy of TACE; how can automated feeder software help?","volume":"53","author":"Abdelsalam","year":"2022","journal-title":"Egypt J Radiol Nucl Med"},{"key":"B45","volume-title":"Applying Superselective Conventional TACE","author":"Miyayama","year":"2017"},{"key":"B46","doi-asserted-by":"publisher","first-page":"7337","DOI":"10.3390\/app10207337","article-title":"Treatment strategy of transarterial chemoembolization for hepatocellular carcinoma","volume":"10","author":"Miyayama","year":"2020","journal-title":"Appl Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1159\/000525500","article-title":"Conventional or drug-eluting beads? Randomized controlled study of chemoembolization for hepatocellular carcinoma: jIVROSG-1302","volume":"11","author":"Ikeda","year":"2022","journal-title":"Liver Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1758835919866072","DOI":"10.1177\/1758835919866072","article-title":"Effectiveness of drug-eluting bead transarterial chemoembolization versus conventional transarterial chemoembolization for small hepatocellular carcinoma in child-Pugh class A patients","volume":"11","author":"Lee","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3348\/kjr.2020.1117","article-title":"Prospective multi-center Korean registry of transcatheter arterial chemoembolization with drug-eluting embolics for nodular hepatocellular carcinoma: a two- year outcome analysis","volume":"22","author":"Lee","year":"2021","journal-title":"Korean J Radiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jvir.2013.06.017","article-title":"Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort","volume":"24","author":"Yoon","year":"2013","journal-title":"J Vasc Intervent Radiol JVIR"},{"key":"B51","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jamaoncol.2017.5847","article-title":"Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs. sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trial","volume":"4","author":"Yoon","year":"2018","journal-title":"JAMA Oncol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1148\/radiology.187.3.8388567","article-title":"Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma","volume":"187","author":"Chung","year":"1993","journal-title":"Radiology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1007\/s00270-019-02232-7","article-title":"Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: variability in technical aspects","volume":"42","author":"Craig","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s00270-004-0299-7","article-title":"A new porcine sponge material for temporary embolization: an experimental short-term pilot study in swine","volume":"29","author":"Louail","year":"2006","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/bjc.2014.199","article-title":"Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma","volume":"111","author":"Golfieri","year":"2014","journal-title":"Br J Cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"W706","DOI":"10.2214\/AJR.13.12308","article-title":"Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC","volume":"203","author":"Prajapati","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00270-014-0907-0","article-title":"Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile","volume":"38","author":"Spreafico","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"742","DOI":"10.2214\/AJR.15.14802","article-title":"Transarterial chemoembolization and (90)Y radioembolization for hepatocellular carcinoma: review of current applications beyond intermediate-stage disease","volume":"205","author":"Fidelman","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1002\/cam4.5125","article-title":"TACE versus TARE for patients with hepatocellular carcinoma: overall and individual patient level meta-analysis","volume":"12","author":"Brown","year":"2023","journal-title":"Cancer Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1514.e5","DOI":"10.1016\/j.cmi.2021.01.014","article-title":"Association between prophylactic antibiotic use for transarterial chemoembolization and occurrence of liver abscess: a retrospective cohort study","volume":"27","author":"Yoshihara","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2169\/internalmedicine.49.3173","article-title":"Antibiotic prophylaxis in transcatheter treatment of hepatocellular carcinoma: an open randomized prospective study of oral versus intravenous administration","volume":"49","author":"Ebisutani","year":"2010","journal-title":"Intern Med (Tokyo, Japan)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1097\/01.RVI.0000244854.79604.C1","article-title":"Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with previous biliary intervention","volume":"17","author":"Patel","year":"2006","journal-title":"J Vasc Intervent Radiol JVIR"},{"key":"B64","doi-asserted-by":"publisher","first-page":"W343","DOI":"10.2214\/AJR.10.6019","article-title":"Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study","volume":"197","author":"Khan","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s1051-0443(90)72508-0","article-title":"Intraarterial administration of lidocaine for analgesia in hepatic chemoembolization","volume":"1","author":"Molgaard","year":"1990","journal-title":"J Vasc Intervent Radiol JVIR"},{"key":"B66","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00270-001-0073-z","article-title":"Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration","volume":"24","author":"Lee","year":"2001","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/liv.13235","article-title":"Risks factors for severe pain after selective liver transarterial chemoembolization","volume":"37","author":"Benzakoun","year":"2017","journal-title":"Liver Intern"},{"key":"B68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jacr.2021.09.029","article-title":"Effect and safety of prophylactic parecoxib for pain control of transarterial chemoembolization in liver cancer: a single-center, parallel-group, randomized trial","volume":"19","author":"Lyu","year":"2022","journal-title":"J Am Coll Radiol JACR"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1007\/s00330-016-4207-8","article-title":"Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial","volume":"26","author":"Lv","year":"2016","journal-title":"Eur Radiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/hep.29403","article-title":"A randomized placebo-controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization","volume":"67","author":"Ogasawara","year":"2018","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"B71","doi-asserted-by":"publisher","first-page":"9059","DOI":"10.12998\/wjcc.v9.i30.9059","article-title":"Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: a randomised, double-blind, placebo-controlled study","volume":"9","author":"Sainamthip","year":"2021","journal-title":"World J Clin Cases"},{"key":"B72","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/s1051-0443(07)61911-3","article-title":"Determinants of postembolization syndrome after hepatic chemoembolization","volume":"12","author":"Leung","year":"2001","journal-title":"J Vasc Intervent Radiol JVIR"},{"key":"B73","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jvir.2011.11.029","article-title":"Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy","volume":"23","author":"Brown","year":"2012","journal-title":"J Vasc Intervent Radiol JVIR"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jvir.2017.04.025","article-title":"Quality improvement guidelines for transarterial chemoembolization and embolization of hepatic malignancy","volume":"28","author":"Gaba","year":"2017","journal-title":"J Vasc Intervent Radiology JVIR"},{"key":"B75","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jvir.2007.11.021","article-title":"Postembolization syndrome: changes in white blood cell counts immediately after uterine artery embolization","volume":"19","author":"Ganguli","year":"2008","journal-title":"J Vasc Intervent Radiol JVIR"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1186674","DOI":"10.3389\/fonc.2023.1186674","article-title":"Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment","volume":"13","author":"Chang","year":"2023","journal-title":"Front Oncol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000343867","article-title":"How to define transarterial chemoembolization failure or refractoriness: a European perspective","volume":"3","author":"Raoul","year":"2014","journal-title":"Liver Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (MRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000368143","article-title":"Validation of the criteria of transcatheter arterial chemoembolization failure or refractoriness in patients with advanced hepatocellular carcinoma proposed by the LCSGJ","volume":"87","author":"Arizumi","year":"2014","journal-title":"Oncology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12876-023-02886-1","article-title":"Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e923263","DOI":"10.12659\/MSM.923263","article-title":"Radiofrequency ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) for patients with Medium-to-large hepatocellular carcinoma: a retrospective analysis of long-term outcome","volume":"26","author":"Liu","year":"2020","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nm988","article-title":"Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer","volume":"10","author":"Willett","year":"2004","journal-title":"Nat Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"14765","DOI":"10.1073\/pnas.93.25.14765","article-title":"Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor\/vascular permeability factor antibody","volume":"93","author":"Yuan","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B84","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science (New York, N.Y.)"},{"key":"B85","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1349-7006.2008.01003.x","article-title":"Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor- beta receptor inhibitor on extravasation of nanoparticles from neovasculature","volume":"100","author":"Kano","year":"2009","journal-title":"Cancer Sci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/s1001-9294(11)60041-2","article-title":"Serum HIF-1alpha and VEGF levels pre- and post-TACE in patients with primary liver cancer","volume":"26","author":"Jia","year":"2011","journal-title":"Chin Med Sci J Chung-Kuo I Hsueh k\u2019o Hsueh Tsa Chih"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/gutjnl-2019-318934","article-title":"Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial","volume":"69","author":"Kudo","year":"2020","journal-title":"Gut"},{"key":"B88","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cancers11081084","article-title":"Lenvatinib as an initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and child-Pugh A liver function: a proof-of-concept study","volume":"11","author":"Kudo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"LBA432","DOI":"10.1200\/JCO.2024.42.3_suppl.LBA43","article-title":"EMERALD-1: a phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization","volume":"42","author":"Lencioni","year":"2024","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Radiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fradi.2026.1763042\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:53:57Z","timestamp":1776776037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fradi.2026.1763042\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":89,"alternative-id":["10.3389\/fradi.2026.1763042"],"URL":"https:\/\/doi.org\/10.3389\/fradi.2026.1763042","relation":{},"ISSN":["2673-8740"],"issn-type":[{"value":"2673-8740","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"article-number":"1763042"}}